Cargando…

Understanding the renin–angiotensin–aldosterone–SARS-CoV axis: a comprehensive review

IMPORTANCE: Coronavirus disease 2019 (COVID-19), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been declared a global pandemic with significant morbidity and mortality since first appearing in Wuhan, China, in late 2019. As many countries are grappling w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingraham, Nicholas E., Barakat, Abdo G., Reilkoff, Ronald, Bezdicek, Tamara, Schacker, Timothy, Chipman, Jeffrey G., Tignanelli, Christopher J., Puskarich, Michael A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	State of the Art
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236830/ https://www.ncbi.nlm.nih.gov/pubmed/32341103 http://dx.doi.org/10.1183/13993003.00912-2020

Ejemplares similares

Antihypertensive drugs and risk of COVID-19?
por: Tignanelli, Christopher J, et al.
Publicado: (2020)

The renin‐angiotensin‐aldosterone system, neurohumoral axis and cardiovascular mortality in LURIC
por: Yazdani, Babak, et al.
Publicado: (2022)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Aliskiren – an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension
por: Zaporowska-Stachowiak, Iwona, et al.
Publicado: (2013)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Management of proteinuria: blockade of the renin–angiotensin–aldosterone system
por: Athavale, Akshay, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Interactions of the DASH Diet with the Renin-Angiotensin-Aldosterone System
por: Maris, Stephen A, et al.
Publicado: (2019)

Erratum for The renin‐angiotensin‐aldosterone system and its suppression
Publicado: (2019)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
por: Coto, Eliecer, et al.
Publicado: (2021)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
por: Hirooka, Kazuyuki, et al.
Publicado: (2022)

Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection
por: Tsampasian, Vasiliki, et al.
Publicado: (2022)

The Renin‐Angiotensin‐Aldosterone System in Greyhounds and Non‐Greyhound Dogs
por: Martinez, J., et al.
Publicado: (2017)

A Comprehensive Insight and Mechanistic Understanding of the Lipidomic Alterations Associated With DCM
por: Saha, Shubham, et al.
Publicado: (2023)

Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression
por: Duman, Ronald S.
Publicado: (2009)

Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections
por: Duman, Ronald S.
Publicado: (2014)

Effects of very low-calorie ketogenic diet on hypothalamic–pituitary–adrenal axis and renin–angiotensin–aldosterone system
por: Barrea, L., et al.
Publicado: (2023)

Hypothalamic-pituitary-adrenal axis and renin-angiotensin-aldosterone system in adulthood PTSD and childhood maltreatment history
por: Kakehi, Ryoko, et al.
Publicado: (2023)

Cardiovascular Risk Reduction with Renin-Angiotensin Aldosterone System Blockade
por: Houston Miller, Nancy
Publicado: (2010)

Recent Update of Renin-angiotensin-aldosterone System in the Pathogenesis of Hypertension
por: Moon, Ju-Young
Publicado: (2013)

Advances in the Renin-Angiotensin-Aldosterone System: Relevance to Diabetic Nephropathy
por: Koitka, Audrey, et al.
Publicado: (2008)

The Interplay Between the Renin-Angiotensin-Aldosterone System and Parathyroid Hormone
por: Zheng, Ming-Hui, et al.
Publicado: (2020)

Effect of renal denervation on catecholamines and the renin–angiotensin–aldosterone system
por: Feyz, Lida, et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
por: Reynolds, Harmony R., et al.
Publicado: (2020)

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
por: Mancia, Giuseppe, et al.
Publicado: (2020)

Risk of Covid-19 with renin-angiotensin-aldosterone system medications
Publicado: (2020)

Antagonizing the renin–angiotensin–aldosterone system in the era of COVID-19
por: Sarzani, Riccardo, et al.
Publicado: (2020)

Role of the Renin–Angiotensin–Aldosterone System in Dystrophin-Deficient Cardiomyopathy
por: Rodriguez-Gonzalez, Moises, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kfd7alhqqbug7svsd9cjn73p9f